BRINTER
Brinter Inc is a pioneering company in 3D bioprinting technology, focusing on developing scalable, high-performance medical devices and applications in regenerative medicine, tissue engineering, and personalized healthcare. The company aims to revolutionize human repairs with bioengineered implants, organ bioprinting, and advanced bioprinting solutions for research, medical, and industrial applications.
Industries
Nr. of Employees
small (1-50)
Products
Modular multi-material 3D bioprinter (research and professional models)
A modular desktop/benchtop 3D bioprinting system that supports multiple interchangeable toolheads for printing hydrogels with cells, pastes, thermoplastics and granulates; configurable with accessories such as mini-PC, laminar hood and medical-grade compressor.
Modular multi-material 3D bioprinter (research and professional models)
A modular desktop/benchtop 3D bioprinting system that supports multiple interchangeable toolheads for printing hydrogels with cells, pastes, thermoplastics and granulates; configurable with accessories such as mini-PC, laminar hood and medical-grade compressor.
Services
Collaborative R&D projects with academic and industry partners to develop bioprinted tissue models, regenerative implants and drug printing applications; includes on-site or partner-lab work for application validation.
Sale and lease of modular multi-material 3D bioprinter systems through channel partners and distributors, supported by outsourced manufacturing and automated fulfillment.
Development of printing methods and process parameters for non-standard materials (e.g., food gels, marmalade), polymer drug formulations, and multi-material constructs tailored to customer research needs.
Collaborative R&D projects with academic and industry partners to develop bioprinted tissue models, regenerative implants and drug printing applications; includes on-site or partner-lab work for application validation.
Sale and lease of modular multi-material 3D bioprinter systems through channel partners and distributors, supported by outsourced manufacturing and automated fulfillment.
Development of printing methods and process parameters for non-standard materials (e.g., food gels, marmalade), polymer drug formulations, and multi-material constructs tailored to customer research needs.
Expertise Areas
- 3D bioprinting platform development
- Tissue engineering and regenerative medicine
- Orthopedic implant design and development
- Patient-specific/precision bioprinting
Key Technologies
- Extrusion-based bioprinting
- Screw-extrusion granulate printing
- Triaxial/concentric extrusion toolheads
- Modular multi-material printheads
News & Updates
Brinter showcased its 3D bioprinting technology at the Bio International Conference in San Diego, engaging with industry leaders and potential partners.
Brinter participated in the MedInvest Conference in Palo Alto, connecting with investors and industry professionals to discuss advancements in MedTech.
Brinter attended the Formnext exhibition in Frankfurt, showcasing its industrial 3D printing solutions.
The objective view of 3D bioprinting, its current state and its effect on the future of life science
An article discussing the current state and future impact of 3D bioprinting in life sciences, featuring insights from Brinter.
A discussion on the potential of bioprinting kidneys for transplants within this decade, highlighting Brinter’s role in the research.
Brinter partnered with LED Tailor to implement an automatic photon disinfection system in its bioprinters, enhancing safety and portability.
Brinter showcased its 3D bioprinting technology at the Bio International Conference in San Diego, engaging with industry leaders and potential partners.
Brinter participated in the MedInvest Conference in Palo Alto, connecting with investors and industry professionals to discuss advancements in MedTech.
Brinter attended the Formnext exhibition in Frankfurt, showcasing its industrial 3D printing solutions.
The objective view of 3D bioprinting, its current state and its effect on the future of life science
An article discussing the current state and future impact of 3D bioprinting in life sciences, featuring insights from Brinter.
A discussion on the potential of bioprinting kidneys for transplants within this decade, highlighting Brinter’s role in the research.
Brinter partnered with LED Tailor to implement an automatic photon disinfection system in its bioprinters, enhancing safety and portability.